3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
12
Prostatic Neoplasms
8
Recurrence
4
Lung Neoplasms
4
Breast Neoplasms
4
Urinary Bladder Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Lymphoma, B-Cell
3
Lymphoma
3
Colorectal Neoplasms
3
Cancer Pain
3
Uterine Cervical Neoplasms
2
Urologic Neoplasms
2
Triple Negative Breast Neoplasms
2
Solid Tumor
2
Small Cell Lung Carcinoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Ovarian Neoplasms
2
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Head and Neck Neoplasms
2
Glioblastoma
2
Cholangiocarcinoma
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Communication Disorders
×
90 days
×
Clear all
NCT04969874
2026-05-12
E-CRIL_MAX
University Hospital, Toulouse
Phase NA
Withdrawn